Learning from the COVID-19 pandemic: health care disturbances and telemedicine as an alternative rheumatology practice in Indonesia

Author:

Parlindungan FaisalORCID,Sumariyono Sumariyono,Hidayat Rudy,Wibowo Suryo Anggoro Kusumo,Ariane Anna,Damanik Johanda,Araminta Abirianty Priandani,Yunita Khadijah Cahya

Abstract

Abstract Background Coronavirus disease 2019 (COVID-19) affects health care services. Our aim was to assess health care disruptions, treatment interruptions, and telemedicine reception regarding autoimmune rheumatic diseases (ARDs) in Indonesia. Method A cross-sectional population online-based questionnaire was conducted in Indonesia from September to December 2021. Results A total of 311 ARD patients were included, of whom 81 (26.0%) underwent consultations via telemedicine during the COVID-19 pandemic. The respondents showed increased concern about their susceptibility to COVID-19 (score of 3.9/5). Approximately 81 (26.0%) avoided hospital visits, and 76 (24.4%) stopped taking the medication without medical advice. Respondents’ concerns correlated with their social distancing behaviors (p value 0.000, r 0.458). Respondent concerns, behaviors, and blocked access to the hospital during the pandemic were associated with avoiding hospital visits (p value 0.014; 0.001; 0.045; 0.008). Sex was associated with stopping medication (p value 0.005). In multivariate analysis, blocked access and sex remained significant. Approximately 81 (26%) respondents who used telemedicine services during the COVID-19 pandemic as an alternative medical consultation method showed high satisfaction (3.8/5). Conclusion Health care disruptions and treatment interruptions were affected by patients’ internal and external factors during the COVID-19 pandemic. Telemedicine may be the best option to address barriers to health care access in Indonesia’s rheumatology practice during and after the pandemic situation.

Publisher

Springer Science and Business Media LLC

Subject

Health Policy

Reference42 articles.

1. Li J, Liu HH, Yin XD, Li CC, Wang J. COVID-19 illness and autoimmune diseases: recent insights. Inflamm Res. 2021;70(4):1. https://doi.org/10.1007/S00011-021-01446-1.

2. Ministry of Home Affair. Java And Bali. Published online August. 2021;2:1–23. Instruction Of The Minister Of Internal Affairs Number 27 Of 2021: Implementation Of Limitations For Community Activities Level 4, Level 3, And Level 2 Corona Virus Disease 2019.

3. Ministry of Home Affair. Instruction Of The Minister Of Affairs Number 28 Of 2021. Sumatera, Kalimantan, Sulawesi, Nusa Tenggara, Maluku And Papua. Published online August. 2021;2:1–11. Implementation Of Restrictions For Community Activities Level 4 Corona Virus Disease 2019.

4. Caso F, Costa L, Ruscitti P, et al. Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects? Autoimmun Rev. 2020;19(5):102524. https://doi.org/10.1016/J.AUTREV.2020.102524.

5. D’Silva KM, Jorge A, Cohen A, et al. COVID-19 outcomes in patients with systemic autoimmune rheumatic Diseases compared to the General Population: a US Multicenter, comparative cohort study. Arthritis Rheumatol. 2021;73(6):914–20. https://doi.org/10.1002/ART.41619.

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3